İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

teva b.v. - gemcitabine - concentrate for solution for infusion - pyrimidine analogues; gemcitabine

Avrupa Birliği - İngilizce - EMA (European Medicines Agency)

celgene europe bv - azacitidine - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - antineoplastic agents - azacitidine celgene is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29 % marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30 % blasts and multi-lineage dysplasia, according to world health organisation (who) classification,aml with >30% marrow blasts according to the who classification.

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

ltt pharma limited - fluorouracil - cream - 5 percent weight/weight - pyrimidine analogues; fluorouracil

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - fluorouracil sodium - solution for injection/infusion - 25 milligram(s)/millilitre - pyrimidine analogues; fluorouracil

İsrail - İngilizce - Ministry of Health

eli lilly israel ltd - gemcitabine as hydrochloride - lyophilic powder for concentrated infusion - gemcitabine as hydrochloride 1 g/vial - pyrimidine analogues - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy.prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.

İsrail - İngilizce - Ministry of Health

eli lilly israel ltd - gemcitabine as hydrochloride - lyophilic powder for concentrated infusion - gemcitabine as hydrochloride 1 g/vial - pyrimidine analogues - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy.prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - gemcitabine - powder for solution for infusion - 1 gram(s) - pyrimidine analogues; gemcitabine

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - gemcitabine - concentrate for solution for infusion - 100 milligram(s)/millilitre - pyrimidine analogues; gemcitabine

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - gemcitabine - powder for solution for infusion - 200 milligram(s) - pyrimidine analogues; gemcitabine

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - gemcitabine hydrochloride - powder for solution for infusion - 2 gram(s) - pyrimidine analogues; gemcitabine